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Background. A standard phenotype of frailty was associated with an increased risk of adverse outcomes including
mortality in a recent study of older adults. However, the predictive validity of this phenotype for fracture outcomes and
across risk subgroups is uncertain.
Methods. To determine whether a standard frailty phenotype was independently associated with risk of adverse health
outcomes in older women and to evaluate the consistency of associations across risk subgroups defined by age and body
mass index (BMI), we ascertained frailty status in a cohort of 6724 women  69 years and followed them prospectively
for incident falls, fractures, and mortality. Frailty was defined by the presence of three or more of the following criteria:
unintentional weight loss, weakness, self-reported poor energy, slow walking speed, and low physical activity. Incident
recurrent falls were defined as at least two falls during the subsequent year. Incident fractures (confirmed with x-ray
reports), including hip fractures, and deaths were ascertained during an average of 9 years of follow-up.
Results. After controlling for multiple confounders such as age, health status, medical conditions, functional status,
depressive symptoms, cognitive function, and bone mineral density, frail women were subsequently at increased risk of
recurrent falls (multivariate odds ratio¼ 1.38, 95% confidence interval [CI], 1.02–1.88), hip fracture (multivariate hazards
ratio [MHR]¼ 1.40, 95% CI, 1.03–1.90), any nonspine fracture (MHR¼ 1.25, 95% CI, 1.05–1.49), and death (MHR¼
1.82, 95% CI, 1.56–2.13). The associations between frailty and these outcomes persisted among women  80 years. In
addition, associations between frailty and an increased risk of falls, fracture, and mortality were consistently observed
across categories of BMI, including BMI  30 kg/m2.
Conclusion. Frailty is an independent predictor of adverse health outcomes in older women, including very elderly
women and older obese women.
FRAILTY is frequently defined variably and has not yetemerged as a discrete clinical syndrome (1,2). In an
attempt to standardize the definition of frailty, Fried and
colleagues (3), using data from the Cardiovascular Health
Study (CHS), proposed a phenotype of frailty in which three
or more of the following five components were present:
unintentional weight loss, self-reported exhaustion, weak-
ness, slow walking speed, and low physical activity.
Findings from their analysis suggested that frail older adults
were at an increased risk of subsequent falls, hospitalization,
disability, and mortality. Another large study of post-
menopausal women aged 65–79 years (4) reported an
association between this phenotype and risk of hip fracture,
but no prior study has examined the relationship between
frailty and other fracture types. In addition, the predictive
validity of this phenotype across risk subgroups is uncertain.
Although prior studies including the analysis from the CHS
cohort have consistently reported that frailty is increasingly
common with advancing age (3–5) and is more frequently
observed in women as compared with men (3,5,6), it is un-
known whether the association between frailty and adverse
health outcomes in older women persists among the oldest old.
In addition,whereas frailty is traditionally considered awasting
disorder common in underweight elderly persons (7), a recent
study in older women (8) reported that obese women were
more likely than nonobese women to be classified in the
intermediate (prefrail) and frail categories. Yet it is uncertain
whether the association between frailty and subsequent risk for
morbidity and mortality is consistently observed among
underweight, normal weight, overweight, and obese women.
We used data collected in the Study of Osteoporotic
Fractures (SOF) to examine whether the frailty phenotype,
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as defined by Fried and colleagues, was independently
associated with adverse health outcomes including recurrent
falls, fractures, and mortality in a cohort of 6724
community-dwelling women aged 69 years and older, and
evaluated whether these associations were consistent across
risk subgroups defined by age and body mass index (BMI).
METHODS
Participants
From September 1986 to October 1988, a total of 9704
women at least 65 years old were recruited for participation
in the baseline examination of the prospective SOF study.
Women were recruited from population-based listings in
four areas of the United States (9). Black women were
originally excluded from SOF because of their low
incidence of hip fracture. In addition, women were excluded
if they were unable to walk without assistance or had
a history of bilateral hip replacement.
All surviving participants were invited to participate in
a fourth examination between 1992 and 1994. A total of
8412 women (97% of survivors as of July 31, 1994)
completed at least the questionnaire component of this
examination. Of these, 6724 women provided data for at
least three frailty components among the five frailty criteria
and are the subject of this analysis.
Measurements
Participants completed a questionnaire and were inter-
viewed during the fourth examination and asked about health
status, education, smoking history, intention to lose weight,
and falls during the previous year. A selected medical history
was obtained, including a history of physician diagnosis of
fracture since the age of 50 years, stroke, diabetes, hyper-
tension, Parkinsonism, dementia, coronary heart disease,
chronic obstructive lung disease, and cancer (except skin
cancer). Participants were asked to bring all prescription and
nonprescription medications, including estrogen preparations,
with them to clinic for verification of use. Physical activity was
assessed using a modified version of the Harvard Alumni
Questionnaire (10,11) and was expressed as a weighted score
of kilocalories expended per week. Depressive symptoms
including the question, ‘‘Do you feel full of energy?’’ were
evaluated using the 15-item Geriatric Depression Scale (12).
Cognitive functionwas assessedwith amodified version of the
Mini-Mental State Examination (13) with a maximum score
of 26. To assess functional disability, women were asked
whether they had any difficulty performing any of five
independent activities of daily living (IADL) (14). Tests of
physical function included grip strength (using a handheld
Jamar dynamometer) and walk speed (time in seconds to walk
6 meters at usual pace). Body weight was recorded with a
balance beam scale at both examinations. Height was mea-
sured using a standard held-expiration technique with a wall-
mounted Harpenden stadiometer (Holtain, U.K.). Height and
weight were used to calculate a standard BMI. Bone mineral
density of the proximal femur wasmeasured using dual energy
x-ray absorptiometry (QDR 1000; Hologic, Waltham, MA).
Frailty
Frailty was operationally defined at the fourth examina-
tion using criteria proposed by Fried and colleagues (3) using
data collected in the CHS study. Frailty was identified by
the presence of three or more of the following components:
1. Shrinking, as identified by an unintentional weight loss
of  5% between the third and fourth examination
(mean years between examinations 2.0 6 0.3);
2. Weakness, as identified at the fourth examination by
a grip strength in the lowest quintile stratified by BMI
(quartiles);
3. Poor energy, as identified at the fourth examination by
an answer of ‘‘no’’ to the question ‘‘Do you feel full of
energy?’’ on the Geriatric Depression Scale (12);
4. Slowness, as identified at the fourth examination by
a walk speed in the lowest quintile stratified by standing
height (median); and
5. Low physical activity level at the fourth examination, as
identified by a weighted score of kilocalories expended
per week in the lowest quintile.
Women with none of the above components were con-
sidered to be robust, and those with one or two components
were considered to be in an intermediate or prefrail stage.
Ascertainment of Falls, Fractures, and Mortality
After the fourth examination, we contacted participants
about falls and fractures every 4 months by postcard or
telephone and were able to complete 98% of these contacts
in surviving women. All falls reported on the first three
postcards returned after the fourth examination (covering
approximately 1 year) were included in the falls analyses
(average follow-up ¼ 11.9 6 0.8 months). Fractures were
confirmed by review of radiographic reports. All first hip
fractures occurring after the fourth examination and before
April 25, 2005 were included in analyses examining the
association between frailty and risk of first hip fracture. Any
nonspine fractures during this period were included in the
analyses examining the relationship between frailty and risk
of any nonspine fracture. Average follow-up was 8.9 6 3.2
years for hip fracture and 7.6 6 3.8 years for any nonspine
fracture. Deaths were identified by contacts every 4 months
and confirmed with death certificates. Follow-up for vital
status was 99% complete. Average follow-up for death was
9.2 6 3.0 years.
Statistical Analysis
Chi-square tests of homogeneity, analyses of variance,
and Kruskal–Wallis tests were used to compare character-
istics of participants at the fourth examination by category
of frailty indicator.
Age-adjusted fracture and mortality rates were calculated.
We used logistic regression to analyze the association
between frailty indicators and the odds of recurrent falls
( 2 vs  1) in the subsequent year. Cox proportional
hazards models were used to analyze the associations be-
tween frailty indicators and subsequent outcomes including
first hip fracture, any incident nonspine fracture, and death.
The relative risk (approximated as hazard ratios [HR] or
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odds ratios [OR]) of each outcome with 95% confidence
intervals (CI) was estimated for women categorized as
intermediate and those categorized as frail using women
who were categorized as robust as the referent group.
Models were initially adjusted for age. To determine
whether frailty was independently associated with the
outcomes of frequent falls, fractures, and death, we
subsequently added covariates to models that included age
as a predictor. To examine whether the association between
frailty indicators and increased risk of adverse health out-
comes persisted among the oldest old, secondary analyses
were performed stratifying participants by age (, 80 years
vs  80 years). Similarly, based on evidence of associations
between frailty and underweight and between frailty and
obesity, analyses were performed to determine whether
relationships between frailty indicators and outcomes were
consistent across categories of BMI (, 18.5 kg/m2
[underweight], 18.5–24.9 kg/m2 [normal weight], 25.0–
29.9 kg/m2 [overweight], and  30 kg/m2 [obese]). We
tested for interactions between the frailty index (ordinal
variable with three levels) and age, and between the frailty
index and BMI for prediction of a given outcome. To assess
if any relationship between frailty indicators and risk of
nonspine fracture was due to an increased risk of hip
fracture, the association between frailty indicators and risk
of nonhip nonspine fracture was analyzed by excluding
women with prior (n ¼ 237) or incident hip fracture (n ¼
668). To examine the effect of fall history on the relation-
ship between frailty indicators and frequent falls, an analysis
was performed stratifying participants by history of any fall
in the previous year (yes vs no). To determine whether
associations between frailty indicators and risk of hip
fracture varied by fracture location, we analyzed the
association between frailty indicators and risk of trochan-
teric fracture and that between frailty indicators and risk of
femoral neck fracture.
The 6724 women eligible for the primary analyses had
three or more nonmissing components among the five
criteria in the frailty index. For each of the 605 women (9%)
missing one component and each of the 182 women (3%)
missing two components, missing values of components
were imputed using the mean of the nonmissing components
for that participant. To examine whether the inclusion of
the 781 women with missing data biased our findings regard-
ing the associations between frailty and outcomes, we
performed a secondary analysis restricted to the 787 women
missing one or two components and a secondary analysis
restricted to the 5937 women with all five components.
Within each of these subcohorts, frail women compared
with robust women had similarly increased age-adjusted
risks of adverse outcomes (recurrent falls, hip fracture, any
nonspine fracture, death). Hence, results of the primary
analyses are presented in this article.
RESULTS
Characteristics of the Study Population
Characteristics of the overall cohort of 6724 women and
the cohort by category of frailty are shown in Table 1.
Compared with the 6724 women included in this analysis
who provided data for at least three frailty components, the
1688 women missing data on three or more components
were more likely to die during follow-up (52% vs 38%, p ,
.001), but were no more likely to experience a first hip
fracture (11% vs 10%, p¼ .685).
Frailty and Risk of Recurrent Falls
During an average follow-up of 11.9 months, 736 (11%)
women experienced  2 (recurrent) falls. Compared with
robust women, women in the intermediate group (OR ¼
1.23, 95% CI, 1.02–1.48) and frail women (OR¼2.41, 95%
CI, 1.93–3.01) had an increased age-adjusted odds of
recurrent falls. After further adjustment for multiple
potential confounders, the associations were diminished in
magnitude, but the OR for frail women (1.38, 95% CI, 1.02–
1.88) remained significant (Table 2).
The associations between frailty indicators and recurrent
falls appeared stronger among women  80 years old than
among those , 80 years old (p¼ .027 for interaction term).
In contrast, the frailty index was associated with recurrent
falls among women with and without a fall history (p¼ .586
for interaction term). Frailty appeared to increase the odds of
recurrent falls across all categories of body weight, though
the association did not reach significance among the 124
underweight women (age-adjusted OR ¼ 2.54, 95%
CI, 0.47–13.87 among underweight women; 3.61, 95%
CI, 2.51–5.17 among normal weight women; 1.95, 95% CI,
1.32–2.88 among overweight women; and 1.68, 95% CI,
1.05–2.68 among obese women). There was some evidence
that the effect of frailty on odds of recurrent falls was less
pronounced among overweight and obese women (p¼ .009
for interaction term).
Frailty and Risk of Fracture
During an average follow-up of 9 years, 2106 (31%)
women experienced  1 nonspine fracture, including 668
(10%) women who suffered a first hip fracture. Of the 668
women with first incident hip fracture, 346 had femoral neck
fractures and 311 had trochanteric fractures.
Compared with robust women, women in the intermedi-
ate group (HR¼ 1.34, 95% CI, 1.12–1.60) and frail women
(HR ¼ 1.70, 95% CI, 1.35–2.15) had an increased age-
adjusted risk of hip fracture. Adjustment for multiple factors
including femoral neck bone density did not entirely explain
the observed associations (multivariate HR [MHR] ¼ 1.27,
95% CI, 1.04–1.56 for women in the intermediate group and
MHR¼ 1.40, 95% CI, 1.03–1.90 for frail women; Table 3).
The associations between frailty indicators and risk of hip
fracture appeared slightly greater in magnitude for trochan-
teric fractures (MHR, 95% CI, 1.39 [1.03–1.88] for women
in the intermediate group and 1.47 [0.94–2.30] for frail
women) than for femoral neck fractures (MHR, 95% CI,
1.19 [0.91–1.57] for women in the intermediate group and
1.28 [0.84–1.97] for frail women).
Frailty indicators were similarly associated with an
increased risk of hip fracture among women , 80 years
old and those  80 years old (p¼ .807 for interaction term).
Although the rates of hip fracture were highest in magnitude
among underweight frail women and obese frail women,
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there was no statistical evidence of an interaction between
the frailty index and BMI for the prediction of hip fracture
risk (p¼ .681 for interaction term).
Frailty was also independently associated with an
increased risk of any nonspine fracture (MHR ¼ 1.25,
95% CI, 1.05–1.49; Table 4). The association between
frailty indicators and an increased risk of any nonspine
fracture was consistently observed among women , 80
years old, among women  80 years old (p ¼ .584 for
interaction term), and across categories of body weight (p¼
.675 for interaction term). When women with a prior or
incident hip fracture were excluded from the analysis, the
relationship between frailty and risk of fracture was smaller
in magnitude and did not reach significance (MHR ¼ 1.18,
95% CI, 0.93–1.49 for any nonhip nonspine fracture).
Frailty and Risk of Mortality
Among the 6724 women followed-up for an average of
9 years, there were 2520 deaths. Increasing evidence of
frailty was strongly associated with higher all-cause
Table 1. Characteristics of Participants for Overall Cohort and by Category of Frailty
Category of Frailty
Variable
Overall Cohort
(N ¼ 6724)
Robust
(N ¼ 2466)
Intermediate
(N ¼ 3162)
Frail
(N ¼ 1096)
p
Value
Age, y, mean 6 SD 76.7 6 4.9 75.3 6 3.9 76.8 6 4.7 79.9 6 5.6 , .001
Self-reported health status, % , .001
Excellent or good 81 95 78 56
Fair 17 5 21 35
Poor or very poor 2 0 1 8
Smoking status, % .017
Current 6 5 6 7
Former 33 33 34 30
Never 61 62 60 63
Current estrogen use, % 18 19 19 15 .036
Education, y, mean 6 SD 12.8 6 2.8 13.0 6 2.7 12.8 6 2.8 12.2 6 2.9 , .001
Any fracture since age 50, % 47 42 48 56 , .001
Selected medical conditions, %* , .001
None 34 44 32 19
1–2 58 53 60 63
 3 8 3 9 17
Any fall in previous year, % 30 26 30 41 , .001
Depressive symptoms
Geriatric Depression Scale score 0–15, mean 6 SD 1.9 6 2.3 0.6 6 1.0 2.2 6 2.2 3.9 6 2.8 , .001
Cognitive function
Mini-Mental Status Examination score 0–26, mean 6 SD 24.4 6 1.9 24.7 6 1.6 24.5 6 1.9 23.7 6 2.6 , .001
IADL impairments range 0–5, mean 6 SD 0.7 6 1.2 0.2 6 0.5 0.6 6 1.1 2.1 6 1.6 , .001
Body mass index, kg/m2, mean 6 SD 26.5 6 4.8 26.1 6 4.2 26.6 6 4.8 26.9 6 5.5 , .001
Femoral neck bone mineral density, g/cm2, mean 6 SD 0.63 6 0.12 0.64 6 0.11 0.63 6 0.12 0.61 6 0.12 , .001
Notes: *History of one or more selected medical conditions including stroke, diabetes, hypertension, Parkinsonism, dementia, coronary heart disease, chronic
obstructive lung disease, and nonskin cancer.
SD ¼ standard deviation; IADL ¼ instrumental activities of daily living.
Table 2. Frailty Status and Risk of Recurrent Falls in Overall Cohort and Risk Subgroup
OR (95% CI)
Age Category Fall in Past Year
Category of Frailty
No. with 
2 Falls (%)
Overall Cohort
(N ¼ 6543)*
, 80 Years
(N ¼ 4879)
 80 Years
(N ¼ 1664)
Yes
(N ¼ 1986)
No
(N ¼ 4546)
Robust (n ¼ 2406) 200 (8) 1.00 1.00 1.00 1.00 1.00
Intermediate (n ¼ 3092) 325 (11) 0.90 (0.72–1.12) 0.84 (0.65–1.07) 1.27 (0.79–2.05) 0.96 (0.70–1.33) 0.85 (0.62–1.15)
Frail (n ¼ 1045) 211 (20) 1.38 (1.02–1.88) 1.31 (0.88–1.94) 1.96 (1.14–3.37) 1.23 (0.79–1.91) 1.39 (0.89–2.18)
Notes: Odds ratios (OR) were adjusted for age; health status; smoking; estrogen use; education; history of fracture; selected medical conditions including stroke,
diabetes, hypertension, Parkinsonism, dementia, coronary heart disease, chronic obstructive lung disease, and nonskin cancer; depressive symptoms; cognitive
function; functional status; body mass index; and femoral neck bone mineral density.
*Among the 6724 women with at least three frailty components, 181 who did not provide fall information at follow-up contacts during the subsequent year were
excluded from this analysis.
CI ¼ confidence interval.
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mortality rates (Table 5). Compared with robust women,
women in the intermediate group had a 1.3-fold increase in
risk (MHR ¼ 1.32, 95% CI, 1.18–1.48), and women
classified as frail had a 1.8-fold increase in risk (MHR ¼
1.82, 95% CI, 1.56–2.13).
The associations between frailty indicators and mortality
appeared slightly greater in magnitude among women
 80 years old than among women , 80 years old (Table
5). However, there was not strong evidence of an
interaction between the frailty index and age for the
prediction of mortality (p¼ .137 for interaction term). The
association between frailty indicators and an increased risk
of death appeared generally consistent across subgroups
defined by BMI (p¼ .350 for interaction term).
DISCUSSION
Increasing evidence of frailty was independently asso-
ciated with increased risks of subsequent falls, fractures,
and all-cause mortality in this cohort of older women,
including among very elderly women and obese older
women.
These results confirm the predictive validity of the
phenotype of frailty as defined by Fried and colleagues (3)
in their analysis of a cohort of 5317 adults  65 years old
enrolled in the CHS. After adjustment for multiple
potential confounders, this phenotype was similarly
associated with increased risks of falls and mortality in
both cohorts. In addition, the magnitude of the association
between frailty and hip fracture in this cohort was similar
to that reported by the Women’s Health Initiative (WHI)
Observational Study (4). Women in the intermediate group
in this cohort appeared to have risks of adverse health
outcomes that were between those of robust women and
those of frail women. These findings are in agreement with
prior studies (3,4,15) using the CHS frailty phenotype.
While results of this study are in general agreement with
those of previous studies examining the association
between frailty and adverse health outcomes in older
people, this investigation extends the work of previous
studies in several ways. Although a number of studies have
indicated that frailty defined in variable ways is in-
creasingly common with advancing age (3–5), these results
suggest that the independent associations between frailty
and risks of recurrent falls, death, and fracture persist
among very elderly women. The magnitude of the
associations between frailty and risks of death and fracture,
including hip fracture, appeared to be similar among
women  80 years old and those 69–79 years old. In
addition, the association between frailty and recurrent falls
was even more pronounced for women aged 80 years and
older compared with younger older women.
While being underweight, experiencing weight loss, and/
or having sarcopenia have been considered to be common
manifestations of frailty in older adults(16–19), a large
cross-sectional study of older women with BMI  18.5 kg/
m2 (8) noted a high prevalence of frailty among obese older
women. In the present prospective study of older women
followed prospectively for outcomes, frailty was similarly
associated with an increased risk of subsequent mortality
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across categories of body weight. The association between
frailty and risk of hip fracture was most pronounced among
underweight women and among obese women with smaller
increases in risk among normal weight and overweight
women. Although there was no statistical evidence of an
interaction between the frailty index and BMI for the
prediction of hip fracture risk, the power to detect this
interaction was limited. Frail women had an increased risk
of recurrent falls across categories of body weight, though
the magnitude of the association was less pronounced
among heavier women.
Although frailty was independently related to hip fracture
risk in this cohort of older women despite adjustment for
strong risk factors including low bone density, the results
suggest that it is only weakly related to other types of
fracture. As reported in prior epidemiologic reviews (20,21),
there may be heterogeneity in the relationship between a risk
factor and skeletal fragility. In addition, the magnitude of
the association between frailty and increased risk of hip
fracture appeared slightly greater for trochanteric hip
fractures than for femoral neck fractures. Previous studies
comparing differences in risk factor patterns between
femoral neck and trochanteric fractures (22–24) have
consistently reported that women with trochanteric fractures
are more likely to be older and have poorer health status and
lower bone density.
Frailty in older people may be associated with increased
risks of adverse health outcomes in older women including
falls, fracture, and mortality for several reasons. Frailty has
been linked to declines in circulating levels of gonadal
hormones, 25-hydroxyvitamin D, growth hormone, and
insulin-like growth factor-1 (IGF-1) (25–27); elevations in
pro-inflammatory cytokines and coagulation factors (26,28–
30); subclinical anemia (31); renal insufficiency (32);
atherosclerosis (33); and anorexia and malnutrition (34).
Alternatively, frailty may be a marker of other conditions
that increase the risk of falls, fractures, and mortality.
However, adjustment for several risk factors including
advanced age, poorer health status, higher prevalence of
medical comorbidities, greater depressive symptoms, poorer
cognitive function, disability, BMI, and lower hip bone
mineral density in this study did not entirely explain the
observed higher rates of adverse health outcomes in frail
older women. These findings lend support to the hypothesis
that frailty in older adults is a unique disorder that is not
entirely explained by advanced age, specific disease states,
and/or degree of disability.
This study has a number of strengths including its
prospective design, comprehensive set of measurements
performed blinded to outcome status, and length and com-
pleteness of follow-up. However, this study has several
limitations. Participants were elderly Caucasian women
living in the community, and our results may not be appli-
cable to other population groups. Adjusting our analyses for
factors such as IADL limitations and depressive symptoms
may have biased our estimates of the associations toward the
null hypothesis. These results may also underestimate the
association between frailty and risk of mortality because
women missing three or more frailty components not
included in the analyses were at highest risk for death.
Inclusion of women missing one or two frailty components
in the analyses may have resulted in misclassification of
women with respect to the intermediate group and frailty
categories. While some misclassification may have oc-
curred, this is unlikely to have been frequent because
missing values of components were imputed using the mean
value of nonmissing components for each participant and
classification of a participant into either the intermediate (1–
2 components) or frail category (3, 4, or 5 components)
involved the collapsing of components. In addition, findings
from sensitivity analyses indicated that inclusion of women
with missing data is unlikely to have biased our findings
regarding the association between frailty and increased risk
of outcomes. Power for evaluating associations between
frailty and outcomes was limited in some risk subgroups,
such as underweight women. Although we queried par-
ticipants every 4 months by postcard or phone, falls may
have been underreported (35). Finally, we defined frailty
using a standard definition, but frailty is frequently defined
variably and our findings may not generalize across different
definitions.
Frail older women are at increased risk of recurrent falls,
fractures, and mortality. This association is consistent across
categories of age and body weight. Future research should
compare the predictive ability of different frailty indices and
identify the biologic and physiologic changes underlying the
disorder.
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